Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Revenue Recognition

I should clarify re: the Js.

While PTSC may "typically" recognize revenue upon contract/license agreement execution, what if the payment terms of the contract call for payment upon occurance of some future event. Until that event, the "product or service" cannot be effectively "delivered" (i.e., they cannot deliver a re-validated patent license until it is indeed re-validated and validity is no longer in question).

I left an opening, and had to close it.

SGE

Share
New Message
Please login to post a reply